2025年，当尹同跃在港交所敲响那面铜锣时，资本市场听到的，可能不只是奇瑞上市的钟声，更是一个信号——那个埋头造了二十多年车、连续23年稳居中 国品牌乘用车出口榜首的"理工男"，开始认真地向外界展示自己赚钱的"新本事"。 2026年伊始，奇瑞集团用一份实现"四大历史突破"的年终答卷，宣告了一个新阶段的开启。2025年，奇瑞集团全年卖出超过280.6万辆车，同比增长7.8%。 这张成绩单的"含金量"十足：出口卖了134.4万辆，连续23年当中国品牌乘用车出口第一；新能源车卖了90.38万辆，猛涨54.9%；还在J.D. Power的评选中， 包揽了新车质量、销售服务等五个核心项目的自主品牌冠军，成为唯一的自主"五冠王"。 这份成绩单的独特之处在于，它并非单一优势的放大，而是资本叙事、技术转型与全球战略协同共振的结果。资本市场开始意识到，奇瑞的故事不止是"卖 得多"和"出得去"那么简单了。奇瑞的增长正从过去的单点突破，转向"出口引领、新能源加速、多品牌协同、品质护航" 的多维均衡发展模式。 港股上市：是融资，更是价值重估的起点 2025年9月25日，奇瑞汽车登陆港交所。上市首日市值一度突破2000亿港元，募资91 ...

The Stock Exchange of Hong Kong Limited and the Securities and Futures Commission take no responsibility for the contents of this Application Proof, make no representation as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this Application Proof. Application Proof of Suzhou Zelgen Biopharmaceuticals Co., Ltd. 蘇州澤璟生物製藥股份有限公司 (the "Company") (A joint stock company incorporated in th ...

Core Viewpoint - The 2025 China Energy Storage CEO Summit highlighted the importance of technological innovation, global collaboration, and safety in the energy storage industry, emphasizing the need for companies to adapt to international markets and enhance their operational capabilities [2][27]. Group 1: Industry Insights - The summit gathered influential leaders from major energy storage companies to discuss breakthroughs in technology, global strategies, and the construction of industrial ecosystems [2]. - Chen Chenghui, Chairman of Kehua Data, emphasized that capturing opportunities requires technological innovation and collaborative standards to overcome development bottlenecks [4]. - Tian Qingjun, Senior Vice President of Envision, stated that for Chinese energy storage companies, going global is no longer optional but essential for survival, advocating for deep localization and talent acquisition [6]. Group 2: Technological Focus - Huang Feng, President of Chuangneng New Energy, highlighted that technology is key to solving performance and cost challenges, and continuous innovation is necessary for value co-creation [8]. - Cui Jian, President of Kehua Energy, noted that network construction technology is a necessity for energy storage, with future systems integrating various functionalities [10]. - Lian Zhanwei, Chairman of New Source Smart Storage, stressed that safety is the lifeline of the energy storage industry, advocating for innovations like immersion liquid cooling to meet high safety demands [14]. Group 3: Globalization and Collaboration - Yang Rui, Chairman of DoubleDeng Co., emphasized the need for energy storage companies to be globally oriented and deeply integrated into international markets, focusing on organizational capabilities to seize market opportunities [12]. - Yang Bao, President of Trina Storage, mentioned leveraging global experience in photovoltaics to facilitate energy storage's international expansion [16]. - Yang Guang, Technical President of Haibo Sichuang, pointed out that strong partnerships and complementary advantages are crucial for stable industry delivery [18]. Group 4: Future Events - The summit served as a precursor to the 14th International Energy Storage Summit and Exhibition (ESIE 2026), scheduled for April 1-3, 2026, in Beijing, where leading companies will showcase their latest technologies and solutions [22][23].

Investment Rating - The report maintains an "Outperform" rating for the company [7][6]. Core Views - The company is advancing its waterproof segment by acquiring Tangshan and Suzhou Yuanda Hongyu, enhancing its regional competitiveness and market share [7]. - The acquisition is deemed reasonably valued, with Tangshan Yuanda Hongyu's price-to-book (PB) ratio at 0.9 times and price-to-earnings (PE) ratio at 4.9 times based on 2024 net profit [7]. - The company is expected to see a recovery in waterproof demand by 2026, which may lead to significant profit elasticity [7]. Financial Data and Profit Forecast - Total revenue is projected to be 25,821 million yuan in 2024, with a slight increase to 25,997 million yuan in 2025, and further growth to 30,551 million yuan by 2027 [6]. - The net profit attributable to the parent company is forecasted to be 3,647 million yuan in 2024, decreasing to 3,516 million yuan in 2025, and then increasing to 4,802 million yuan by 2027 [6]. - The company's return on equity (ROE) is expected to improve from 9.6% in 2025 to 14.3% by 2027 [6]. Market Data - As of November 28, 2025, the closing price of the company's stock is 25.31 yuan, with a market capitalization of 42,761 million yuan [2]. - The company has a dividend yield of 3.42%, and its price-to-earnings ratio is projected to be 12 for 2025, decreasing to 9 by 2027 [2][6].

Financial Data and Key Metrics Changes - The company reported consolidated net revenue of $36.3 million, a 6% increase year over year, driven by higher cannabis flower sales in Israel and higher cannabis extract sales in Canada, partially offset by a decrease in cannabis flower sales in Canada [11] - Gross profit and adjusted gross profit in Q3 were $18.3 million, equating to a 50% gross margin, a 19 percentage point improvement from 31% adjusted gross margins in Q3 2024 [11] - Adjusted EBITDA in Q3 was $5.7 million, an improvement of $11.7 million year-over-year, driven by higher gross profit and lower operating expenses [12] Business Line Data and Key Metrics Changes - In Canada, flower supply constraints led to softer flower revenue year over year, but this was offset by strong performance in edibles and significant growth in the vape category [4] - The Spinach brand ended the quarter as the number two cannabis brand in Canada with 4.5% overall market share, ranking fourth in flower with 4.9% share and third in vapes with 7% share [5] - In edibles, Spinach held the number one position with 19.7% market share, and within gummies, it led the market with 22.8% share [6] Market Data and Key Metrics Changes - In Israel, Cronos Group achieved record net revenue, with Peace Naturals being the number one medical cannabis brand, driven by strong demand for flagship strains [8] - The medical patient count in Israel has returned to growth in 2025, up nearly 5% year to date [9] - International market results were lighter this quarter due to shipment timing, with expectations for the second half of 2025 net revenue to be similar to the first half [9] Company Strategy and Development Direction - The company remains focused on delivering top-line growth, margin expansion, and disciplined cost management while strengthening operations for sustainable profitability [4] - The completion of the phase two expansion at GrowCo is expected to improve flower sales in 2026, resolving supply constraints [5] - Cronos Group maintains a strong balance sheet with no debt and $824 million in cash, providing flexibility for growth and innovation [10] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's strategy and highlighted the strong performance of core business segments, anticipating continued growth into 2026 [15] - The company is optimistic about the impact of the Groco expansion on revenue and margins, with expectations for improved capacity utilization over time [17][19] Other Important Information - The company launched new products, including limited-edition seasonal offerings and new strains in Israel, to maintain consumer engagement and retail momentum [7][8] - The company is monitoring potential regulatory changes in Germany that could affect future market dynamics [9] Q&A Session Summary Question: Did any sales from Groco expansion occur in Q3, and what is the expected growth magnitude for 2026? - Management indicated that sales from Groco would gradually show up, with a 70% capacity increase on flower expected to impact revenue positively in 2026 [17] Question: Will underlying gross margins improve with the new Groco capacity? - Management confirmed that increased fixed cost absorption from the new facility could lead to improved margins in the future [18] Question: How much did flower supply constraints impact Q3, and what about shipment timing for international markets? - Management acknowledged that flower supply constraints weighed down performance, and shipment timing shifts would normalize, making the second half of the year similar to the first half [20][21]

Core Insights - The company has transformed from a "phase hotspot" to a "sustainable benchmark" in the health industry, driven by a dual strategy of "medical + consumer" [1] - The company achieved a compound annual revenue growth rate of approximately 15%, with projected revenue of 9 billion yuan for 2024, reflecting its commitment to stability and innovation [1] - The company has established a global supply chain network and a diverse product matrix, showcasing its strategic determination and innovative spirit [1] Financial Performance - In the first half of 2025, the company reported revenue of 5.3 billion yuan, a year-on-year increase of 31.3%, and a net profit of 490 million yuan, with a growth rate of 28.1% [3] - The medical segment generated revenue of 2.52 billion yuan, up 46.4%, while the consumer segment achieved 2.75 billion yuan, a growth of 20.3% [4][6] Product Development and Innovation - The company has invested 1.808 billion yuan in R&D over five years, maintaining a research intensity of over 3% of revenue [9] - The development of cotton-based medical consumables has positioned the company as a leader in sustainable practices, with 1,109 patents in medical consumables and 986 in consumer products [12] Global Expansion - The company has expanded its overseas sales channels, achieving revenue of 1.43 billion yuan in the first half of 2025, a growth of 81.3% [14] - The acquisition of GRI in the U.S. has enhanced the company's capabilities in R&D, manufacturing, and sales, facilitating its transition from "product export" to "brand export" [14] ESG and Social Responsibility - The company has received a Wind ESG rating of A, with a score of 7.53, ranking in the top 21% of its industry [15] - The company emphasizes social value creation, contributing to agricultural modernization and responding to public health emergencies [16]

Core Insights - Chery's IPO on September 25, 2023, marked a significant milestone in its 28-year history, with oversubscription exceeding 238 times and strong backing from 13 cornerstone investors, highlighting global capital's recognition of Chinese manufacturing [1] - The company's journey from humble beginnings in a thatched house to becoming a global manufacturing benchmark is attributed to its commitment to technology-driven enterprise [1] Group 1: Cultural Foundation - Chery's enduring corporate culture, rooted in the spirit of resilience and gratitude, serves as a competitive advantage, fostering internal confidence and cohesion among employees [2] - The leadership style of CEO Yin Tongyue emphasizes collective learning and consensus-building, contrasting with the typical top-down management approach in the industry [2] - Three cultural genes—Wuhu's Hui merchant spirit, a dedication to engine technology, and the "thatched house" ethos—form the backbone of Chery's corporate identity, enabling it to overcome challenges and maintain a forward-looking mindset [2][3] Group 2: Technological Innovation - Chery's revenue is projected to grow from 92.6 billion in 2022 to 269.9 billion in 2024, driven by a robust commitment to technological innovation and a comprehensive R&D ecosystem [4] - The company has significantly increased its R&D investment from 4.1 billion in 2022 to 10.5 billion in 2024, with a compound annual growth rate of nearly 60% [5] - Chery's advancements in powertrain technology, including the ACTECO engine series and proprietary transmission systems, have positioned it as a leader in both fuel and electric vehicle markets [5][6] Group 3: Global Strategy - Chery has established a strong global presence, exporting to over 100 countries and achieving top sales among Chinese brands in key markets like Europe and South America [8][9] - The company's new factory in Barcelona represents a significant step in localizing production in Europe, enhancing its global supply chain and service network [8][10] - Future plans include expanding production capacity in Vietnam and Malaysia, as well as increasing R&D personnel to develop products tailored to local markets [10]